Lexaria's Patented Technology Significantly Enhances Oral Delivery of Antiviral Drugs

Stock Information for Hill Street Beverage Company Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Hill Street Beverage Company Inc.

Lexaria Announces Effective Date for Reverse Stock Split
Lexaria Expands COVID-19 Drug Research Program Utilizing Proprietary DehydraTECH
Lexaria Closes Sale of Non-Pharmaceutical THC-Related Assets
Lexaria Bioscience Corp. Discusses Demonstration of Improved Oral Delivery for Antiviral Drugs with The Stock Day Podcast
Lexaria to Highlight its DehydraTECHTM Technology at Four Upcoming Investor Conferences
Lexaria to Highlight its DehydraTECH(TM) Technology at Four Upcoming Investor Conferences
Lexaria Bioscience Sells Non-Pharmaceutical THC-Related Assets for CDN$3.85M
Lexaria Bioscience Corp. Discusses the Significance of Their Intellectual Property with The Stock Day Podcast

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.